Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116693542A details silver-catalyzed spiro tetrahydroquinoline synthesis. Offers high purity, mild conditions, and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel synthesis method for pyrazinyl oxadiazole compound offers cost reduction in pharma intermediate manufacturing and high-purity supply chain reliability.
Discover a cost-effective synthesis of ganaxolone via direct methylation. Enhanced purity and supply chain reliability for pharmaceutical intermediates.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel chiral resolution route for Levosimendan intermediates ensures high optical purity and scalable production for global pharmaceutical supply chains.
Novel patent CN112624981B details a high-yield route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN118048636A reveals mild cobalt-catalyzed electrochemical route. Offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN106432199B reveals ultrasonic resolution for high-purity Ondansetron. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel Pd-catalyzed synthesis offers high yield and enantioselectivity for antibacterial pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Novel synthesis method for SHP2 CDK4 inhibitor intermediate improves yield and reduces palladium residue for reliable supply chain.
Patent CN117756739B reveals Pd NHC catalysis for benzazepine lactones. Offers mild conditions and antibacterial applications for reliable pharmaceutical intermediates supply chains.
Novel DMAP-catalyzed esterification patent CN108424383A offers high yield 89.4%. Reliable curcumin nicotinate supplier ensuring cost reduction and supply continuity.
Novel metal-free method using DMSO for high-yield ketone synthesis. Offers cost-effective scalable solutions for global pharmaceutical supply chains.
Patent CN116332787B reveals a safer acetylation route for contrast agent intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN119019271A reveals a novel salbutamol synthesis route offering high purity and cost reduction in API manufacturing for global supply chains.
Novel synthesis route for chiral spiro amine intermediates using Grubbs catalyst ensures high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Advanced Pd-catalyzed synthesis of ortho-deuterated benzoic acid derivatives. High selectivity, recyclable directing groups, and scalable manufacturing for pharmaceutical intermediates.
Patent CN119219602A reveals a novel Cu-catalyzed radical cyclization for 4-lauryl-β-lactam derivatives, offering high atom economy and scalable pharmaceutical intermediate production.
Novel hydroxide-based synthesis offers high selectivity and cost reduction for pharmaceutical intermediates supply chain stability and commercial scalability ensuring reliable sourcing.
Novel nickel-catalyzed route for Bilastine key intermediate reduces toxicity and cost, offering a scalable supply chain solution for global pharmaceutical manufacturers.